This brand name is authorized in Nigeria.
The drug DICGEM contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
L4D5UA6CB4 - DICLOFENAC POTASSIUM
|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
|
2
|
UNII
362O9ITL9D - ACETAMINOPHEN
|
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-6287 | Tablet | Dicgem Tablet TAB 50 mg; 500 mg 10 x 10's | Uncoated Tablet White color oval shape biconvex one side embossed “DICGEM” and other side break line uncoated tablet 160 RNW-PP-160423 DICGEM TABLET DICLOFENAC POTASSIUM 50mg /PARACETAMOL BP 500MG TABLETS DICLOFENAC SODIUM 50MG , PARACETAMOL 500MG A4-6287 Drugs Imported Products 10X10tablets Prescription Only Medicine (POM) 1/21/2021 YELLOW PHARMACEUTICAL COMPANY LIMITED., , EKWULOBIA STREET WOLIWO LAYOUT, ONITSHA ANAMBRA 8090970669 yellowpharmaltd@gmail.com M/S LACTOSE (INDIA) LTD., KHASRA NO.SURVEY NO.6, VILLAGE ,POICHA (RANIA) TALUKA SAVLI, DISTRICT -VADODARA, GUJARAT -391-780, INDIA , India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M01AB55 | Diclofenac, combinations | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-6287 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.